Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual
- PMID: 9708240
- PMCID: PMC1745218
- DOI: 10.1136/thx.53.5.430
Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual
Abstract
Infection with Burkholderia cepacia due to social contact is well described in patients with cystic fibrosis. However, social transmission to non-cystic fibrosis individuals or chronic colonisation in non-cystic fibrosis individuals has not been described. A report of B cepacia bronchiectasis is presented where a previously healthy mother of two cystic fibrosis children colonised with B cepacia became infected by the same epidemic strain. The implications of this for parents, siblings, and partners of individuals with cystic fibrosis are discussed.
Comment in
-
Burkholderia cepacia bronchiectasis.Thorax. 1999 Jan;54(1):92. doi: 10.1136/thx.54.1.91b. Thorax. 1999. PMID: 10343643 Free PMC article. No abstract available.
-
Nebulised taurolidine and B cepacia bronchiectasis.Thorax. 2000 Jan;55(1):91-2. doi: 10.1136/thorax.55.1.91a. Thorax. 2000. PMID: 10681263 Free PMC article. Clinical Trial. No abstract available.
Similar articles
-
Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia.Thorax. 1998 May;53(5):432-6. doi: 10.1136/thx.53.5.432. Thorax. 1998. PMID: 9708241 Free PMC article.
-
Use of pulsed-field gel electrophoresis in infection control issues concerning Burkholderia cepacia.Infect Control Hosp Epidemiol. 2003 Aug;24(8):624-6. doi: 10.1086/502265. Infect Control Hosp Epidemiol. 2003. PMID: 12940588
-
Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.Thorax. 1995 Nov;50(11):1194-8. doi: 10.1136/thx.50.11.1194. Thorax. 1995. PMID: 8553277 Free PMC article.
-
Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas.Eur Respir J. 2001 Feb;17(2):295-301. doi: 10.1183/09031936.01.17202950. Eur Respir J. 2001. PMID: 11334134 Review.
-
The environmental risk factors associated with medical and dental equipment in the transmission of Burkholderia (Pseudomonas) cepacia in cystic fibrosis patients.J Hosp Infect. 1996 Apr;32(4):249-55. doi: 10.1016/s0195-6701(96)90035-3. J Hosp Infect. 1996. PMID: 8744509 Review.
Cited by
-
Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.Thorax. 2002 Feb;57(2):142-5. doi: 10.1136/thorax.57.2.142. Thorax. 2002. PMID: 11828044 Free PMC article.
-
Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.Infect Immun. 2001 Aug;69(8):5138-50. doi: 10.1128/IAI.69.8.5138-5150.2001. Infect Immun. 2001. PMID: 11447196 Free PMC article.
-
The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?Drugs. 2000 Nov;60(5):1053-64. doi: 10.2165/00003495-200060050-00006. Drugs. 2000. PMID: 11129122 Review.
-
Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.J R Soc Med. 2000;93 Suppl 38(Suppl 38):40-5. J R Soc Med. 2000. PMID: 10911818 Free PMC article. Review. No abstract available.
-
Burkholderia cepacia infection in a non-cystic fibrosis patient: an arcane presentation.Access Microbiol. 2021 Apr 15;3(4):000222. doi: 10.1099/acmi.0.000222. eCollection 2021. Access Microbiol. 2021. PMID: 34151173 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical